Home » Closed Trials

Dose-finding evaluation of an oral PARP inhibitor plus COP chemotherapy for dogs with lymphoma

21 May 2009 No Comment

Dog Target Accrual= 9 cases
Status: Closed
Eligibility:

* Measurable nodal lymphoma- cytological or histological diagnosis
* All clinical stages but must have nodal involvement – includes relapsed cases
* Favorable performance score
* Recent COP treatment discouraged

Trial Support: Owner is responsible for referral examination and CBC/Chemistry/UA at initial study visit. Study provides full support for radiographs, lymph node biopsies (total of 3), lymph node immunophenotyping, bloodwork required by the study, study drug, COP protocol x 6 weeks, and recheck examinations for the first 6 weeks of the protocol.

Comments are closed.